2nd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

Student Loan Auction Rate Securities

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Branded prescription pharmaceutical fee under the Accountable Care Act

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare coverage and reimbursement issues (cuts to Medicare Part B and coverage of obesity medications)

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Education EDU

Student Loan Auction Rate Securities

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Senator Mike Crapo

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Food and Drug Administration-Drug Enforcement Agency coordination and scheduling issues drug importation Prescription Drug User Fee Act reauthorization (HOPE Act, supply chain integrity)

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.